PA8534001A1 - Derivados de piperazina 1,4-disustituida utiles como bloqueadores alfa1,-adrenoceptores uro-selectivos - Google Patents

Derivados de piperazina 1,4-disustituida utiles como bloqueadores alfa1,-adrenoceptores uro-selectivos

Info

Publication number
PA8534001A1
PA8534001A1 PA20018534001A PA8534001A PA8534001A1 PA 8534001 A1 PA8534001 A1 PA 8534001A1 PA 20018534001 A PA20018534001 A PA 20018534001A PA 8534001 A PA8534001 A PA 8534001A PA 8534001 A1 PA8534001 A1 PA 8534001A1
Authority
PA
Panama
Prior art keywords
alfa1
uro
disposed
blockers
compounds
Prior art date
Application number
PA20018534001A
Other languages
English (en)
Inventor
Nitya Anand
Sanjay Jain
Neelima Sinha
Anita Chugh
Laxminarayan G Hedge
Jang Bahadur Gupta
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of PA8534001A1 publication Critical patent/PA8534001A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A CIERTOS NUEVOS DERIVADOS DE PIPERAZINA 1,4-DISUSTITUIDA DE FORMULA I, Y SUS SALES DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLES CON EXCELENTE ACTIVIDAD ANTAGONISTA ALFA1-ADRENOCEPTORA URO-SELECTIVA QUE EXCEDE AQUELLA DE COMPUESTOS PREVIAMENTE DESCRITOS. LOS COMPUESTOS DE LA PRESENTE INVENCION SE PRESENTAN PROMETEDORES PARA EL TRATAMIENTO DE LOS SINTOMAS DE LA HIPERPLASIA PROSTATICA BENIGNA (BPH). LA INVENCION TAMBIEN SE REFIERE A LOS METODOS PARA LA ELABORACION DE LOS NUEVOS COMPUESTOS, DE LAS COMPOSICIONES FARMACEUTICAS QUE CONTIENEN DICHOS COMPUESTOS Y AL METODO PARA EL TRATAMIENTO DE LOS SINTOMAS DE LA HIPERPLASIA PROSTATICA BENIGNA CON EL USO DICHOS COMPUESTOS.
PA20018534001A 2000-11-30 2001-11-29 Derivados de piperazina 1,4-disustituida utiles como bloqueadores alfa1,-adrenoceptores uro-selectivos PA8534001A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1097DE2000 2000-11-30

Publications (1)

Publication Number Publication Date
PA8534001A1 true PA8534001A1 (es) 2002-12-11

Family

ID=11097130

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20018534001A PA8534001A1 (es) 2000-11-30 2001-11-29 Derivados de piperazina 1,4-disustituida utiles como bloqueadores alfa1,-adrenoceptores uro-selectivos

Country Status (25)

Country Link
US (1) US6914064B2 (es)
EP (1) EP1339682A1 (es)
JP (1) JP2004514711A (es)
KR (1) KR20030068164A (es)
CN (1) CN1230423C (es)
AP (1) AP2003002810A0 (es)
AR (1) AR035930A1 (es)
AU (2) AU2002222315B2 (es)
BG (1) BG107943A (es)
BR (1) BR0115865A (es)
CA (1) CA2430343A1 (es)
CZ (1) CZ20031698A3 (es)
DO (1) DOP2001000296A (es)
EA (1) EA006941B1 (es)
EE (1) EE200300250A (es)
HU (1) HUP0400545A3 (es)
MA (1) MA26064A1 (es)
MX (1) MXPA03004850A (es)
NZ (1) NZ526226A (es)
OA (1) OA12537A (es)
PA (1) PA8534001A1 (es)
PL (1) PL362210A1 (es)
SK (1) SK8052003A3 (es)
WO (1) WO2002044151A1 (es)
ZA (1) ZA200304242B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002253429A1 (en) * 2002-04-08 2003-10-20 Ranbaxy Laboratories Limited ALPHA, OMEGA-DICARBOXIMIDE DERIVATIVES AS USEFUL URO-SELECTIVE Alpha1Alpha ADRENOCEPTOR BLOCKERS
WO2005037281A1 (en) * 2003-10-15 2005-04-28 Ranbaxy Laboratories Limited 1-alkylpiperazinyl-pyrrolidin-2, 5-dione derivatives as adrenergic receptor antagonist
EP1746998A1 (en) * 2004-03-22 2007-01-31 Ranbaxy Laboratories, Ltd. Combination therapy for lower urinary tract symptoms
WO2005113498A1 (en) * 2004-05-19 2005-12-01 Ranbaxy Laboratories Limited Adrenergic receptor antagonists
US20090312344A1 (en) * 2004-05-31 2009-12-17 Mohammad Salman Arylpiperazine derivatives as adrenergic receptor antagonists
WO2006018815A1 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Piperazine derivatives as adrenergic receptor antagonists
WO2006051399A1 (en) * 2004-11-11 2006-05-18 Ranbaxy Laboratories Limited Piperazine derivatives useful as adrenergic receptor antagonists
WO2006051374A2 (en) * 2004-11-11 2006-05-18 Ranbaxy Laboratories Limited Arylpiperazines useful as adrenergic receptor antagonists
WO2006092710A1 (en) * 2005-03-02 2006-09-08 Ranbaxy Laboratories Limited Metabolites of 2-{3-[4-(2-isopropoxyphenyl) piperazin-1-yl]-propyl}-3a,4,7,7a-tetrahydro-1h-isoindole-1,3-(2h)-dione
WO2006117760A1 (en) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited Adrenergic receptor antagonists
WO2007029156A2 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Isoindoledione derivatives as adrenergic receptor antagonists
WO2007039809A1 (en) * 2005-10-05 2007-04-12 Ranbaxy Laboratories Limited Metabolites of 2- {3-[4-(5-fluoro-2-isopropoxy-phenyl)-piperazin-1-yl]-propyl} -5,6-dihydroxy-hexahydro-isoindole-1,3-dione
JP5701213B2 (ja) 2008-10-10 2015-04-15 インスティチュート オブ ファーマコロジー アンド トキシコロジー アカデミー オブ ミリタリー メディカル サイエンシズ ピー.エル.エー.チャイナ 新規なドーパミンd3受容体リガンド、その調製及び使用
US9227944B2 (en) 2008-10-10 2016-01-05 Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China Dopamine D3 receptor ligands and preparation and medical uses of the same
SG10201402054UA (en) 2009-05-05 2014-09-26 Muthiah Manoharan Lipid compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57197265A (en) * 1981-05-29 1982-12-03 Eisai Co Ltd Carboxylic acid imide derivative, its preparation and medicament containing the same
JPS5936661A (ja) * 1982-08-26 1984-02-28 Eisai Co Ltd カルボン酸イミド誘導体およびその製造方法ならびにそれを含有する医薬
JPS5976059A (ja) * 1982-10-21 1984-04-28 Sumitomo Chem Co Ltd 環状イミド誘導体及びその酸付加塩
JPS5995267A (ja) * 1982-11-25 1984-06-01 Eisai Co Ltd カルボン酸イミド誘導体およびその製造方法
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
AT387773B (de) * 1983-09-12 1989-03-10 Bristol Myers Co Verfahren zur herstellung von 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)aklyl) iperazin-derivaten
JPS60204784A (ja) 1984-03-29 1985-10-16 Eisai Co Ltd カルボン酸イミド誘導体
JP2918899B2 (ja) 1989-03-09 1999-07-12 住友製薬株式会社 環状イミド誘導体の製造方法
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
DE69612698T2 (de) * 1995-06-09 2001-12-06 Hoffmann La Roche Pyrimidindion-, Pyrimidintrion-, Triazindion-Derivate als alpha-1-adrenergische Rezeptorantagonisten
WO1998037893A1 (fr) 1997-02-26 1998-09-03 Sumitomo Pharmaceuticals Co., Ltd. Antagoniste du recepteur dopaminergique d4
PT984777E (pt) * 1997-05-12 2004-01-30 Ortho Mcneil Pharm Inc Piperazinas arilsubstituidas uteis no tratamento da hiperplasia benigna da prostata
US6083950A (en) * 1997-11-13 2000-07-04 Ranbaxy Laboratories Limited 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockers

Also Published As

Publication number Publication date
EA200300620A1 (ru) 2003-12-25
AP2003002810A0 (en) 2003-06-30
AU2231502A (en) 2002-06-11
SK8052003A3 (en) 2003-12-02
CZ20031698A3 (cs) 2003-11-12
EE200300250A (et) 2003-10-15
CA2430343A1 (en) 2002-06-06
DOP2001000296A (es) 2003-03-15
ZA200304242B (en) 2004-03-02
EP1339682A1 (en) 2003-09-03
KR20030068164A (ko) 2003-08-19
JP2004514711A (ja) 2004-05-20
CN1486300A (zh) 2004-03-31
WO2002044151A1 (en) 2002-06-06
MA26064A1 (fr) 2004-04-01
AR035930A1 (es) 2004-07-28
MXPA03004850A (es) 2004-01-26
HUP0400545A3 (en) 2007-05-02
BG107943A (bg) 2004-08-31
OA12537A (en) 2006-06-05
US20020156085A1 (en) 2002-10-24
NZ526226A (en) 2004-05-28
HUP0400545A2 (hu) 2004-07-28
BR0115865A (pt) 2003-12-23
US6914064B2 (en) 2005-07-05
CN1230423C (zh) 2005-12-07
PL362210A1 (en) 2004-10-18
AU2002222315B2 (en) 2007-06-21
EA006941B1 (ru) 2006-06-30

Similar Documents

Publication Publication Date Title
PA8534001A1 (es) Derivados de piperazina 1,4-disustituida utiles como bloqueadores alfa1,-adrenoceptores uro-selectivos
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
GT200100137A (es) Pro-drogas de derivados de 4-fenil-piridina.
ES2139959T3 (es) Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2.
ES2196377T3 (es) Derivados de naftiridina.
UY27740A1 (es) Nuevos compuestos
UY26797A1 (es) Derivados de purina
AR008377A1 (es) Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto
ES2195785B1 (es) Nuevos derivados de piridazin-3(2h)-ona.
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
ECSP034444A (es) Derivados de 4-amino-6-fenil-pirrolo(2,3-d)pirimidina
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
AR007456A1 (es) Compuestos derivados de indazol sustituido y composiciones farmaceuticas que lo contienen
PA8432901A1 (es) Compuestos de piridilpirrol
ES2188426B1 (es) Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias.
PE20050012A1 (es) Compuestos de benzopirano como inhibidores de la ciclooxigenasa-2
PA8532001A1 (es) Bifenilcarboxamidas utiles como agentes reductores de lipidos
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
BR9911250A (pt) Processo para preparação de compostos
GT200100232A (es) Derivados de pirimidina.
ES2192263T3 (es) Derivados de benzo(c)quinolizina, su preparacion y empleo como inhibidores de 5-alfa-reductasas.
ES2189072T3 (es) Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR0013306A (pt) Processos úteis na sìntese de compostos antipicornavirais
PA8444901A1 (es) Derivados de 5-aroilnaftaleno como agentes anti-inflamatorios